| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2023 | OPALGENIX INC | 612 POMEROY ST | INDIANAPOLIS | IN | 46202-3277 | MARION | USA | R43HL167661 | Improving Analgesic Effectiveness and Safety with Proactive Precision Pain Management in Thoracic Surgical Patients with Lung Lesions | 000 | 1 | NIH | 12/8/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | OPALGENIX INC | 612 POMEROY ST | INDIANAPOLIS | IN | 46202-3277 | MARION | USA | R43DA058430 | Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy | 000 | 1 | NIH | 5/22/2025 | $0 |
| | 2025 | 2021 | OPALGENIX INC | 612 POMEROY ST | INDIANAPOLIS | IN | 46202-3277 | MARION | USA | R41DA053877 | Avoiding Adverse Opioid Outcomes with Proactive Precision Care | 000 | 1 | NIH | 2/5/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | OPALGENIX INC | 612 POMEROY ST | INDIANAPOLIS | IN | 46202-3277 | MARION | USA | R44DA056280 | Reducing Opioid Use and Adverse Effects through Proactive Precision Pain Management Following Spine Surgery | 000 | 1 | NIH | 5/14/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $969,664 ) |
| | 2023 | 2023 | OPALGENIX, INC. | 3250 WHISPERING PINES LN | CARMEL | IN | 46032-4431 | HAMILTON | USA | R43DA058430 | Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy | 000 | 1 | NIH | 5/1/2023 | $325,239 |
| | 2023 | 2023 | OPALGENIX INC | 612 POMEROY ST | INDIANAPOLIS | IN | 46202-3277 | MARION | USA | R43HL167661 | Improving Analgesic Effectiveness and Safety with Proactive Precision Pain Management in Thoracic Surgical Patients with Lung Lesions | 000 | 1 | NIH | 7/26/2023 | $644,425 |
| | 2023 | 2021 | OPALGENIX, INC. | 3250 WHISPERING PINES LN | CARMEL | IN | 46032-4431 | HAMILTON | USA | R41DA053877 | Avoiding Adverse Opioid Outcomes with Proactive Precision Care | 000 | 1 | NIH | 5/25/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $381,500 ) |
| | 2022 | 2022 | OPALGENIX, INC. | 3250 WHISPERING PINES LN | CARMEL | IN | 46032-4431 | HAMILTON | USA | R44DA056280 | Reducing Opioid Use and Adverse Effects through Proactive Precision Pain Management Following Spine Surgery | 000 | 1 | NIH | 7/15/2022 | $326,500 |
| | 2022 | 2022 | OPALGENIX, INC. | 3250 WHISPERING PINES LN | CARMEL | IN | 46032-4431 | HAMILTON | USA | R41DA053877 | Avoiding Adverse Opioid Outcomes with Proactive Precision Care | 000 | 1 | NIH | 2/2/2022 | $55,000 |
|
| Issue Date FY: 2021 ( Subtotal = $319,447 ) |
| | 2021 | 2021 | OPALGENIX, INC. | 3250 WHISPERING PINES LN | CARMEL | IN | 46032-4431 | HAMILTON | USA | R41DA053877 | Avoiding Adverse Opioid Outcomes with Proactive Precision Care | 000 | 1 | NIH | 6/17/2021 | $319,447 |
|
|
